Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2020 TO 2029]"
journalStr:"The Lancet. Infectious diseases"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22The+Lancet.+Infectious+diseases%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22The+Lancet.+Infectious+diseases%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22The+Lancet.+Infectious+diseases%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (40)
1
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine : a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Oda, Y.
|
Kumagai, Y.
|
Kanai, M.
| +8
Wird geladen...
2
Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants : a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Rivera Mejía, L.
|
Peña Méndez, L.
|
Bandyopadhyay, A.
| +9
ErratumIn: Lancet Infect Dis. 2024 Jan 3;:. - PMID 38184006
Wird geladen...
3
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis : pooled data from two prospective randomised controlled trials
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Thompson, G.
|
Soriano, A.
|
Honore, P.
| +14
Wird geladen...
4
Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia : a randomised, double-blind, non-inferiority, phase 2b/3 trial
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Sprecher, V.
|
Hofmann, D.
|
Savathdy, V.
| +7
Wird geladen...
5
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China : a multicentre, double-blind, phase 3, randomised controlled study
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Fan, X.
|
Dai, X.
|
Ling, Y.
| +36
Wird geladen...
6
Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali : a double-blind, randomised, controlled, phase 3 trial
enthalten in:
The Lancet. Infectious diseases
| 2024
von
Dicko, A.
|
Ouedraogo, J.
|
Zongo, I.
| +33
Wird geladen...
7
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT) : a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
enthalten in:
The Lancet. Infectious diseases
| 2023
von
Bramante, C.
|
Buse, J.
|
Liebovitz, D.
| +106
CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1096-1097. - PMID 37302405
Wird geladen...
8
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults : a multicentre, open-label phase 3 trial
enthalten in:
The Lancet. Infectious diseases
| 2023
von
Li, J.
|
Hou, L.
|
Gou, J.
| +23
CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1099-1100. - PMID 37352881
Wird geladen...
9
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK : a randomised, observer-blind, active-controlled trial
enthalten in:
The Lancet. Infectious diseases
| 2023
von
Lee, I.
|
Cosgrove, C.
|
Moore, P.
| +64
CommentIn: Lancet Infect Dis. 2023 Sep;23(9):984-985. - PMID 37348518
Wird geladen...
10
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex : a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
enthalten in:
The Lancet. Infectious diseases
| 2023
von
Kaye, K.
|
Shorr, A.
|
Wunderink, R.
| +11
CommentIn: Lancet Infect Dis. 2023 Sep;23(9):994-995. - PMID 37182533
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Zeitschrift: The Lancet. Infectious diseases
Medienart
40
Aufsätze
40
E-Artikel
40
E-Ressourcen
Zeitschriftentitel
The Lancet. Infectious diseases
Thema
40
Clinical Trial, Phase III
40
Journal Article
35
Randomized Controlled Trial
29
Research Support, Non-U.S. Gov't
21
Multicenter Study
12
Antibodies, Viral
9
COVID-19 Vaccines
9
Clinical Trial, Phase II
6
Antibodies, Neutralizing
4
70288-86-7
4
Anti-Bacterial Agents
4
Comparative Study
4
Ivermectin
4
Viral Vaccines
3
Anthelmintics
3
Equivalence Trial
3
Papillomavirus Vaccines
3
Research Support, N.I.H., Extramural
3
Vaccines, Conjugate
3
Vaccines, Inactivated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
6
2024
8
2023
14
2022
11
2021
1
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
40
Englisch
Haven't found what you're looking for?
Wird geladen...